Definitive testing not medically necessary
Payers deny definitive testing without a documented reason, such as an unexpected presumptive result.
How we prevent it: We review orders and presumptive results before billing definitive tests.
Toxicology labs face strict medical-necessity and frequency rules for presumptive and definitive drug testing, and are frequently audited.
Upfront or setup fees
Revenue cycle steps managed end to end
Specialties and lab types we bill for
Of your data and systems stay yours
Toxicology labs face strict medical-necessity and frequency rules for presumptive and definitive drug testing. Medicare and many commercial plans limit how often testing is covered and how many drug classes can be tested.
Definitive testing is billed by the number of drug classes with Medicare G-codes, while many commercial plans use CPT codes by drug. Orders must be individualized, and specimen validity testing is included in the drug testing codes.
We bill toxicology with orders, presumptive results and drug classes verified before submission, so claims meet the LCD and payer policies and survive audits.
Also see our medical coding, denial management, eligibility verification and revenue cycle management services.
Drug testing codes depend on the method and, for definitive testing, the number of drug classes.
| Code | Description | What we watch for |
|---|---|---|
| 80305 | Presumptive drug class screening, read by direct optical observation | For cups and dipsticks; once per date of service. |
| 80306 | Presumptive drug class screening, read by instrument-assisted direct optical observation | Once per date of service. |
| 80307 | Presumptive drug class screening by instrument chemistry analyzers | Once per date of service, regardless of the number of classes. |
| G0480 | Definitive drug testing, 1–7 drug classes | Medicare code; billed once per date of service. |
| G0481 | Definitive drug testing, 8–14 drug classes | Higher class counts face more medical necessity review. |
| G0482 | Definitive drug testing, 15–21 drug classes | Requires documented need for each class. |
| G0483 | Definitive drug testing, 22 or more drug classes | Rarely supported for routine monitoring. |
| 80320 | Alcohols, definitive | Commercial definitive code; Medicare uses G-codes instead. |
| 80365 | Oxycodone, definitive | Commercial plans may require codes per drug. |
| 82570 | Creatinine, other source | Not billed separately for specimen validity in drug testing. |
Code descriptions are summarized. CPT® is a registered trademark of the American Medical Association. Coverage and payment rules vary by payer and change every year; we code to the current code set and your payers’ policies.
CLIA-waived testFor waived presumptive tests billed to Medicare.
ABN on fileFor testing that may not be covered.
Expected denial, no ABNReports that denial is expected without an ABN.
Distinct serviceFor separately necessary services on the same date.
The denial reasons we see most often in toxicology lab billing, with the claim adjustment reason code (CARC) payers usually attach, and what we do so they don't happen again.
Payers deny definitive testing without a documented reason, such as an unexpected presumptive result.
How we prevent it: We review orders and presumptive results before billing definitive tests.
LCDs limit how often drug testing is covered for a patient.
How we prevent it: We track test dates and the patient’s risk level.
Specimen validity testing is included in drug testing codes.
How we prevent it: Our edits stop separate validity billing.
Standing or blanket orders that are not patient-specific are not accepted.
How we prevent it: We verify that orders list the patient-specific tests and reason.
The lab’s CLIA certificate must cover the test complexity.
How we prevent it: We match tests to CLIA complexity and keep certificates current.
From the first eligibility check to the final patient payment, one dedicated team handles every step and reports back to you.
We verify coverage, benefits, copays and deductibles before the visit. For toxicology, that includes order review and payer drug testing policy checks.
Our coders review documentation and assign CPT, HCPCS and ICD-10-CM codes to the highest supported specificity. Tests are coded by method and drug class from the requisition and results.
Every claim is checked against NCCI edits, payer policies and modifier rules before it goes out electronically, so it is paid on the first pass.
We post ERAs and EOBs, compare payments to your contracted rates and flag underpayments for appeal.
Every denial is worked: corrected, appealed or escalated, with root causes fed back to the front end. Necessity and frequency denials are appealed with orders and clinical notes.
You get clear monthly reports on collections, denials and A/R aging, and patients get easy-to-read statements and answers to billing questions.
Rules that change how toxicology lab claims must be coded, documented and submitted.
LCD requirements: Medicare’s drug testing LCDs define when presumptive and definitive testing are covered.
Drug class counting: G0480–G0483 depend on the number of drug classes tested.
Specimen validity: included in drug testing codes and not separately billable.
Orders: must be individualized and signed by the treating provider.
Send us a sample of your toxicology lab denials and A/R. We'll show you where revenue is slipping and how we'd fix it, with no obligation and no upfront fees.